FDA Law Weekly

California State University, Long Beach - Meals identified as healthy choices on restaurant menus are healthy

Cardiome Pharma Corp. - Additional ACT 1 clinical results reported

Center for Molecular Immunology, Havana - New findings in vaccines adjuvant described

Central Drug Research Institute, Uttar Pradesh - Melittin analyzed, hemolytic role of leucine zipper motif revealed

Chalmers University of Technology, Gothenburg - Lipid sponge phase as a transdermal drug delivery vehicle discussed

Chang Gung University & Memorial Hospital - Thymalfasin may treat patients with chronic hepatitis B

Chungbuk National University, Cheongju - Protein microarray chips unearth new peptides with therapeutic potential

Commonwealth Biotechnologies - Research organization posts record 2004 revenues

Compugen, Ltd. - Drug- and diagnostic-discovery company reports $13.7M net loss for 2004

Cornell University, Ithaca - Nanobiohybrids implement fluorescent protein transfection

Cylene Pharmaceuticals - Oncology company moves HQ and R&D operations to San Diego facility

DOBI Medical International, Inc. - Diagnostics company names Michael Silver VP of clinical research

Deakin University, Warrnambool - Lack of permanent pools from intermittent streams reduced algal productivity

Diet & Nutrition - Reading, writing and waistlines? Bill calls for kids to be weighed

Diet & Nutrition - Report: Wellness programs key to boosting online weight loss programs' success

Domantis, Ltd. - Domain antibody company joins European effort to discover new CVD treatments

Dresden University of Technology - Two major 8-prenylnaringenin metabolites are estrogenic in vitro

Drug Abuse - Zoners approve methadone dispensing on Bay Street in Vermont

Eotvos L. University - Bioactive peptide conjugates characterized using thioether linkages

European Institute of Oncology, Milano - Findings in breast cancer provide new insights

Forest Laboratories, Inc. - Confirmatory study of desmoteplase begins

Johnson & Johnson Pharmaceutical Services - U.S. FDA grants approval to ovarian cancer treatment following data submission

Kensey Nash Corporation - Company responds to FDA regarding 510K application for TriActiv System

Legal Issues - St. Francis Hospital settles vaccine fraud case

Medical Malpractice - Attorneys take sides on medical malpractice reform issue

Mental Health - Broward hospital disciplined for treatment of Baker Act patients

Morton Grove Pharmaceuticals - Pharma company cleared to market Megestrol Acetate Oral Suspension

Mylan Laboratories Inc. - Pharma company receives approval for Citalopram Hydrobromide tablets

NitroMed, Inc. - U.S. FDA accepts NDA resubmission for BiDil

Pain Management - New study links Vioxx, Celebrex, Bextra to increased cardiovascular risk

Santarus, Inc. - Results from ZEGERID Chewable Tablet trials announced

State Medicaid - Hospitals cite free care in arguing for Medicaid funding

U.S. Food & Drug Administration - DNA vaccine protects mice against primary TB infection

U.S. Food & Drug Administration - Genomic segments of influenza B virus strains mapped

U.S. Food & Drug Administration - Studies add new findings to diagnostics body of knowledge

U.S. Minnesota Department of Health, Eagan - Hand washing compliance in food service dependent on knowledge of supervisor

U.S. National Institutes of Health - New findings in dengue fever described